• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类胶质瘤中1p和19q上常见缺失区域的定位及其与组织学亚型的关联。

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

作者信息

Smith J S, Alderete B, Minn Y, Borell T J, Perry A, Mohapatra G, Hosek S M, Kimmel D, O'Fallon J, Yates A, Feuerstein B G, Burger P C, Scheithauer B W, Jenkins R B

机构信息

Division of Laboratory Genetics, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

出版信息

Oncogene. 1999 Jul 15;18(28):4144-52. doi: 10.1038/sj.onc.1202759.

DOI:10.1038/sj.onc.1202759
PMID:10435596
Abstract

Allelic alterations of chromosomes 1 and 19 are frequent events in human diffuse gliomas and have recently proven to be strong predictors of chemotherapeutic response and prolonged survival in oligodendrogliomas (Cairncross et al., 1998; Smith et al., submitted). Using 115 human diffuse gliomas, we localized regions of common allelic loss on chromosomes 1 and 19 and assessed the association of these deletion intervals with glioma histological subtypes. Further, we evaluated the capacity of multiple modalities to detect these alterations, including loss of heterozygosity (LOH), fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). The correlation coefficients for detection of 1p and 19q alterations, respectively, between modalities were: 0.98 and 0.87 for LOH and FISH, 0.79 and 0.60 for LOH and CGH, and 0.79 and 0.53 for FISH and CGH. Minimal deletion regions were defined on 19q13.3 (D19S412-D19S596) and 1p (D1S468-D1S1612). Loss of the 1p36 region was found in 18% of astrocytomas (10/55) and in 73% (24/33) of oligodendrogliomas (P < 0.0001), and loss of the 19q13.3 region was found in 38% (21/55) of astrocytomas and 73% (24/33) of oligodendrogliomas (P = 0.0017). Loss of both regions was found in 11% (6/55) of astrocytomas and in 64% (21/33) of oligodendrogliomas (P < 0.0001). All gliomas with LOH on either 1p or 19q demonstrated loss of the corresponding FISH probe, 1p36 or 19q13.3, suggesting not only locations of putative tumor suppressor genes, but also a simple assay for assessment of 1p and 19q alterations as diagnostic and prognostic markers.

摘要

染色体1和19的等位基因改变在人类弥漫性胶质瘤中是常见事件,最近已被证明是少突胶质细胞瘤化疗反应和延长生存期的有力预测指标(Cairncross等人,1998年;Smith等人,待发表)。我们使用115例人类弥漫性胶质瘤,定位了染色体1和19上常见等位基因缺失区域,并评估了这些缺失区间与胶质瘤组织学亚型的关联。此外,我们评估了多种检测这些改变的方法的能力,包括杂合性缺失(LOH)、荧光原位杂交(FISH)和比较基因组杂交(CGH)。各方法之间检测1p和19q改变的相关系数分别为:LOH与FISH检测1p改变的相关系数为0.98,检测19q改变的相关系数为0.87;LOH与CGH检测1p改变的相关系数为0.79,检测19q改变的相关系数为0.60;FISH与CGH检测1p改变的相关系数为0.79,检测19q改变的相关系数为0.53。在19q13.3(D19S412 - D19S596)和1p(D1S468 - D1S1612)上定义了最小缺失区域。在18%(10/55)的星形细胞瘤和73%(24/33)的少突胶质细胞瘤中发现1p36区域缺失(P < 0.0001),在38%(21/55)的星形细胞瘤和73%(24/33)的少突胶质细胞瘤中发现19q13.3区域缺失(P = 0.0017)。在11%(6/55)的星形细胞瘤和64%(21/33)的少突胶质细胞瘤中发现两个区域均缺失(P < 0.00

相似文献

1
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.人类胶质瘤中1p和19q上常见缺失区域的定位及其与组织学亚型的关联。
Oncogene. 1999 Jul 15;18(28):4144-52. doi: 10.1038/sj.onc.1202759.
2
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
3
[Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].原发性脑肿瘤病例中1号和19号染色体杂合性缺失
Ugeskr Laeger. 2006 Oct 30;168(44):3813-6.
4
[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].[1号和19号染色体杂合性缺失与胶质瘤中MGMT、p53和Ki-67蛋白表达的相关性]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8.
5
Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?1p/19q 缺失是否为少突胶质细胞瘤的诊断标志物?
Cancer Genet Cytogenet. 2009 Oct;194(1):12-22. doi: 10.1016/j.cancergencyto.2009.05.004.
6
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.通过阵列比较基因组杂交技术在人类少突胶质细胞瘤和混合性少突星形细胞瘤中检测到的染色体失衡。
Genes Chromosomes Cancer. 2005 Jan;42(1):68-77. doi: 10.1002/gcc.20108.
7
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.少突胶质细胞瘤和低级别弥漫性星形细胞瘤的表型与基因型相关性
Acta Neuropathol. 2002 Mar;103(3):267-75. doi: 10.1007/s004010100464. Epub 2001 Nov 22.
8
Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.少突胶质细胞瘤和胶质母细胞瘤中1p和19q的等位基因状态:多重连接依赖性探针扩增与杂合性缺失
Cancer Genet Cytogenet. 2009 Apr 15;190(2):93-6. doi: 10.1016/j.cancergencyto.2008.09.017.
9
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.91例星形细胞瘤和少突胶质细胞瘤中1p、19q、10q、TP53、EGFR、CDK4和CDKN2A的组织学与分子遗传学分析的相关性
Clin Cancer Res. 2002 Jan;8(1):196-201.
10
Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.人类少突胶质细胞瘤中1号、10号和19号染色体异常的分子分析:杂合性缺失频率与分级、年龄及性别的关系
Clin Neuropathol. 2006 Jan-Feb;25(1):18-24.

引用本文的文献

1
Diagnostic challenges in complicated case of glioblastoma.胶质母细胞瘤复杂病例的诊断挑战。
Pathol Oncol Res. 2024 Oct 29;30:1611875. doi: 10.3389/pore.2024.1611875. eCollection 2024.
2
Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.EMP1、2、3 在肾上腺皮质肿瘤和嗜铬细胞瘤中的表达。
Int J Mol Sci. 2023 Aug 21;24(16):13016. doi: 10.3390/ijms241613016.
3
The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma.低级别胶质瘤中预后干性相关特征的复发性特异性调控网络。
Dis Markers. 2023 Jan 17;2023:2243928. doi: 10.1155/2023/2243928. eCollection 2023.
4
True anaplastic oligoastrocytoma with dual genotype: illustrative case.具有双重基因型的真性间变性少突星形细胞瘤:病例说明
J Neurosurg Case Lessons. 2022 Jul 18;4(3):CASE22146. doi: 10.3171/CASE22146.
5
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.泛素蛋白酶体系统基因可作为星形细胞和少突胶质细胞来源的恶性神经胶质瘤的差异标志物。
Cell Mol Neurobiol. 2023 May;43(4):1425-1452. doi: 10.1007/s10571-022-01261-0. Epub 2022 Jul 27.
6
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
7
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.1p/19q 缺失检测在少突胶质细胞瘤诊断中的准确性:一项基于 Cochrane 系统评价的综合荟萃分析。
Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12790. doi: 10.1111/nan.12790. Epub 2022 Mar 3.
8
A Systems Approach to Brain Tumor Treatment.一种脑肿瘤治疗的系统方法。
Cancers (Basel). 2021 Jun 24;13(13):3152. doi: 10.3390/cancers13133152.
9
Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.IDH1-R132H 突变型而非非典型 IDH1/2 突变和 1p/19q 联合缺失型少突胶质细胞瘤中频繁出现 H3K27 三甲基化丢失:一项日本队列研究。
Acta Neuropathol Commun. 2021 May 21;9(1):95. doi: 10.1186/s40478-021-01194-7.
10
Construction of a SUMOylation regulator-based prognostic model in low-grade glioma.基于 SUMOylation 调节剂的低级别胶质瘤预后模型的构建。
J Cell Mol Med. 2021 Jun;25(12):5434-5442. doi: 10.1111/jcmm.16553. Epub 2021 May 5.